<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0">
<channel>


<title>aktiencheck.de - Forum - Monte Rosa Therapeutics Inc</title>
<link>http://www.aktiencheck.de</link>
<description>aktiencheck.de</description>
<language></language>
<copyright>aktiencheck.de</copyright>
<lastBuildDate>Thu, 28 May 2026 18:36:31 +0200</lastBuildDate>
<ttl>2</ttl>








<item>
<title>Therapie durch gezielten Proteinabbau</title>
<link>http://www.aktiencheck.de/forum/Therapie_durch_gezielten_Proteinabbau-A3CS44-t576635</link>
<guid>http://www.aktiencheck.de/forum/Therapie_durch_gezielten_Proteinabbau-A3CS44-t576635</guid>
<description>Angebot von Stammaktien, https://www.globenewswire.com/news-release/2026/01/07/3214890/0/en/Monte-Rosa-Therapeutics-Announces-Proposed-Public-Offering-of-Common-Stock-and-Pre-Funded-Warrants. [&lt;a href=&#034;http://www.aktiencheck.de/forum/Therapie_durch_gezielten_Proteinabbau-A3CS44-t576635&#034;&gt;mehr&lt;/a&gt;]</description>
</item>

</channel>
</rss>







